Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Curevac N.V. (CVAC)

Curevac N.V. (CVAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Curevac N.V. Friedrich-Miescher-Strasse 15 Tubingen 2M 72076 DEU

www.curevac.com P: 49-70-71988-30 F: 719-883-1101

Description:

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

Key Statistics

Overview:

Market Capitalization, $K 582,088
Enterprise Value, $K 59,718
Shares Outstanding, K 223,880
Annual Sales, $ 71,030 K
Annual Net Income, $ -262,380 K
Last Quarter Sales, $ 17,940 K
Last Quarter Net Income, $ -52,980 K
EBIT, $ -219,020 K
EBITDA, $ -194,010 K
60-Month Beta 2.51
% of Insider Shareholders 2.15%
% of Institutional Shareholders 17.26%
Float, K 219,067
% Float 97.85%
Short Volume Ratio 0.44

Growth:

1-Year Return -67.32%
3-Year Return -97.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 11/14/23
Latest Earnings Date 06/04/24
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr 27.27%
EPS Growth vs. Prev Year 129.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CVAC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -369.39%
Debt/Equity 0.00
Price/Sales 11.70
Price/Cash Flow N/A
Price/Book 0.83
Book Value/Share 2.93
Interest Coverage -66.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar